Home › All Companies › BBLGW › Annual Report

Bone Biologics Corp (BBLGW) — Annual Report

AI-Powered SEC Filing Analysis

← All BBLGW filings
Latest Annual Report Filed: 2026-03-02

Key Insights

  • The company had a net loss of $X.X million in 2025, an increase from the previous year's net loss of $X.X million, indicating ongoing operational challenges.
  • Bone Biologics Corp raised $X.X million in a public offering in March 2024, which may provide additional funding to support its business operations.
  • The company had $X.X million in cash and cash equivalents as of December 31, 2025, which may be sufficient to fund its operations for the next X months based on its current burn rate.
Sentiment: Negative Significance: 6/10
View Original Filing →

Want the newest filings?

This analysis covers the filing from 2026-03-02. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Other reports for Bone Biologics Corp

Current Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.